ask="3.37"
ask_size="200"
average_daily_volume="151242"
bid="3.06"
bid_size="1800"
book_value="0.74"
change="-0.05"
change_from_200_day_moving_average="0.55"
change_from_50_day_moving_average="0.27"
change_from_52_week_high="-0.69"
change_From_52_week_low="1.67"
change_in_percent="-1.57%"
close="3.13"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="21613000"
high="3.39"
high_52_weeks="3.82"
last_trade_date="1/19/2017"
last_trade_price="3.13"
last_trade_size="100"
last_trade_time="3:59pm"
low="3.12"
low_52_weeks="1.46"
market_capitalization="106.88M"
moving_average_200_day="2.58"
moving_average_50_day="2.86"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.83"
open="3.22"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+21.28%"
percent_change_from_50_day_moving_average="+9.53%"
percent_change_from_52_week_high="-18.06%"
percent_change_from_52_week_low="+114.38%"
previous_close="3.18"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.28"
price_per_sales="24.40"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="3.18"
stock_exchange="NGM"
symbol="FATE"
volume="181815"
weeks_range_52="1.46 - 3.82"
